Landscapes / Companies
Chengdu Kangnuoxing Biopharma,Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials
Trials
3 active
3 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Artificial immunoglobulin |
Keymed Biosciences |
Approved in China | Dec 2026Phase 3 trial completes | ||
| How it works | An antibody | ||||
| Next date | Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Seasonal Allergic Rhinitis (SAR), Bullous Pemphigoid (BP) | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021